CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020		Sep. 30, 2019
Adjustments to reconcile net income (loss) to net cash provided from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (228.5)		$ 398.2
Depreciation and amortization	292.2		260.8
Deferred income taxes and investment tax credits, net	(168.4)		25.2
Equity in (earnings) losses of unconsolidated affiliates	703.8	[1]	(104.8)
Distributions from unconsolidated affiliates	73.3		107.3
Allowance for equity funds used during construction	(3.7)		(3.7)
Stock-based compensation expense	6.7		10.8
Regulatory assets	(8.5)		(48.1)
Regulatory liabilities	(48.6)		(32.1)
Other assets	(3.7)		(4.3)
Other liabilities	(39.2)		5.1
Change in certain current assets and liabilities:
Accounts receivable and accrued unbilled revenues, net	(62.9)		(76.4)
Increase (Decrease) in Income Taxes Receivable	10.0		0.0
Fuel, materials and supplies inventories	(2.0)		8.0
Fuel recoveries	74.3		(44.8)
Other current assets	(6.3)		3.4
Accounts payable	(68.6)		(69.1)
Other current liabilities	5.4		(17.5)
Net cash provided from operating activities	525.3		418.0
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures (less allowance for equity funds used during construction)	(419.7)		(476.5)
Investment in unconsolidated affiliates	(2.4)		(5.9)
Net cash used in investing activities	(422.1)		(482.4)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issuance of Long-term Debt	297.1		296.4
Increase (decrease) in short-term debt	(112.0)		168.8
Payment of long-term debt	(0.1)		(250.0)
Dividends paid on common stock	(234.4)		(221.7)
Net cash used in financing activities	(71.2)		(16.7)
NET CHANGE IN CASH AND CASH EQUIVALENTS	32.0		(81.1)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	0.0		94.3
CASH AND CASH EQUIVALENTS AT END OF PERIOD	32.0		13.2
Proceeds from (Payments for) Other Financing Activities	(7.1)		(10.2)
Treasury Stock, Value, Acquired, Cost Method	$ (14.7)		$ 0.0

[1] In March 2020, the Company recorded a $780.0 million impairment on its investment in Enable, as further discussed in Notes 4 and 5.